NCT00206076View on ClinicalTrials.gov

Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Liver Disease

Interventions

DRUG

mycophenolate mofetil

mycophenolate mofetil and half their baseline dose of calcineurin inhibitor

DRUG

mycophenolate mofetil

mycophenolate mofetil monotherapy

Trial Locations (3)

19141

Albert Einstein Medical Center, Philadelphia

Unknown

University of Kentucky at Lexington, Lexington

Texas Transplant Institute, San Antonio

All Listed Sponsors

collaborator

Hoffmann-La Roche

INDUSTRY

lead

Albert Einstein Healthcare Network

OTHER

NCT00206076 - Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation | Biotech Hunter | Biotech Hunter